The National Cancer Institute's research programs are extensive and contain many innovative initiatives. I invite you to explore our Web site to find out more about the exciting work being conducted here at NCI and by NCI-supported scientists throughout the country.
You will also find valuable cancer-related information of all kinds. For the general public, patients, and health professionals, we offer consumer-oriented information on a wide range of topics as well as comprehensive descriptions of our research programs and clinical trials. Scientists will find detailed information on specific areas of research interest and funding opportunities.
The Myelodysplastic Syndromes Foundation was established by an international group of physicians and researchers to provide an ongoing exchange of information relating to MDS.
Until the Foundation was set up, no formal working group had been devoted to MDS. During the past decade we have conducted eight international symposia —in Austria, England, the United States, Spain, Czech Republic, Sweden, France, and Japan. The Ninth International Symposium is being held in May 2007 in Florence, Italy.
A major Foundation effort is our international information network. This network provides patients with referrals to Centers of Excellence, contact names for available clinical trials, sharing of new research and treatment options between physicians, and extension of educational support to both physicians and patients.
To date, the MMRF has raised more than $60 million to fund 51 laboratories worldwide. As good stewards of your funds, the MMRF is proud to channel 92% of dollars raised into supporting the most cutting-edge myeloma research worldwide.
Leukaemia Research was established in 1960 and is still the only national research charity devoted exclusively to leukaemia, the lymphomas, myeloma, aplastic anaemia, myelodysplasia, the myeloproliferative disorders and the related blood disorders in both children and adults.
The Leukemia & Lymphoma Society is the world's largest voluntary health organization dedicated to funding blood cancer research, education, and patient services. The Society's mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families.
A major goal of the IARC is the identification of causes of cancer, so that preventive measures may be adopted against them. The Governing Council has repeatedly stated that research dealing with treatment and other aspects of cancer patient care should not be a part of IARC’s mission, nor should the Agency be directly involved in the implementation of control measures, except in cases where it is necessary in order to assess the effectiveness of the mechanisms of carcinogenicity, or when the experimental intervention is needed to permit identification of causes. IARC does not deal in the formulation of policies or legislation aiming at controlling carcinogens either.
RSS / Subscribe